A meta-analysis showed that increased CRP levels have been significantly associated with higher glioma risk, and also, CRP may serve a powerful biomarker for a worse prognosis in glioma patients, as well as an independent predictor for the overall survival in subjects with glioblastoma [874,875]. Here, CRP is linked to glioma.